Month: January 2022

METHADOSE (methadone hydrochloride) oral concentrate, CII

METHADOSE (methadone hydrochloride) oral concentrate, CII

METHADOSE contains methadone, an opioid agonist indicated for the detoxification treatment of opioid addiction (heroin or other morphine-like drugs) and maintenance treatment of opioid addiction (heroin or other morphine-like drugs), in conjunction with appropriate social and medical services.

GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)

GENVOYA ® (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)

GENVOYA is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 25 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen

BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide)

BIKTARVY ® (bictegravir, emtricitabine, and tenofovir alafenamide)

BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg who have no antiretroviral treatment history or to replace the current antiretroviral regimen

EPINEPHRINE INJECTION USP

EPINEPHRINE INJECTION USP

Epinephrine acts on both alpha (α)- and beta (β)-adrenergic receptors. Hypotension associated with Septic Shock: Epinephrine Injection USP, 1 mg/mL is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.